The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Maviret
Australian Public Assessment Report
Device/Product Name
Maviret
Active ingredients
Glecaprevir and pibrentasvir
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-06602-1-2
Submission Type
Major variation and extension of indication
Decision
Approved